The silencing of fructose-1,6-bisphosphatase (FBP1) increases cancer cells’ reliance on glucose metabolism, concurrently reducing ROS levels through decreased mitochondrial respiration while enhancing NADPH production via the pentose phosphate pathway. This evidence concerns the gene FBP1 and cancer.